Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Ting‑Wei Lu"'
Autor:
Shi-Yuan Yang, Yue Hu, Ran Zhao, Yu-Ning Zhou, Yu Zhuang, Yan Zhu, Xiao-Li Ge, Ting-Wei Lu, Kai-Li Lin, Yuan-Jin Xu
Publikováno v:
Journal of Nanobiotechnology, Vol 22, Iss 1, Pp 1-19 (2024)
Abstract Background Impaired osteo-/angiogenesis, excessive inflammation, and imbalance of the osteoimmune homeostasis are involved in the pathogenesis of the alveolar bone defect caused by periodontitis. Unfortunately, there is still a lack of ideal
Externí odkaz:
https://doaj.org/article/47b55d7a432d4298b08941d25a020faf
Autor:
Shi‑Yuan Yang, Yue Hu, Ran Zhao, Yu‑Ning Zhou, Yu Zhuang, Yan Zhu, Xiao‑Li Ge, Ting‑Wei Lu, Kai‑Li Lin, Yuan‑Jin Xu
Publikováno v:
Journal of Nanobiotechnology; 3/6/2024, Vol. 22 Issue 1, p1-19, 19p, 2 Diagrams, 8 Graphs
Autor:
Ting-Wei Lu, Yue Huang, Shou-Qiang Lai, Su-Hui Lin, Shi-Biao Liu, Xiao-Tong Fan, Yi-Jun Lu, Yue Lin, Zhong Chen, Ting-Zhu Wu
Publikováno v:
Journal of Lightwave Technology. :1-11
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::74096c27ac62b430078fe9da2a1bd249
https://doi.org/10.1109/jlt.2023.3236374
https://doi.org/10.1109/jlt.2023.3236374
Autor:
Shou-Qiang Lai, Ting-Wei Lu, Su-Hui Lin, Yi Lin, Guo-Chun Lin, Jian-Hua Pan, Yue-Long Zhuang, Yi-Jun Lu, Yue Lin, Hao-Chung Kuo, Zhong Chen, Ting-Zhu Wu
Publikováno v:
IEEE Transactions on Electron Devices. 69:4936-4943
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::41f8f4550c0cf0f84bf5693acc620ca0
https://doi.org/10.1109/ted.2022.3188738
https://doi.org/10.1109/ted.2022.3188738
Publikováno v:
The Chinese journal of dental research : the official journal of the Scientific Section of the Chinese Stomatological Association (CSA). 25(1)
To conduct a systemic review for guidance regarding the application of templates in mandibular reconstruction with vascularised iliac flaps.By searching PubMed, EMBASE and the Cochrane Library and collecting relevant literature, information about the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8ece439327a0fc22d69b8ef5c236a6f9
https://pubmed.ncbi.nlm.nih.gov/35293709
https://pubmed.ncbi.nlm.nih.gov/35293709
Publikováno v:
2017 International Conference on Applied System Innovation (ICASI).
NFinFET devices with channel length 100nm and 120nm fabricated on SOI (silicon on insulator) wafers are measured to show I D -V G and I D -V D characteristic curves. I D -V G characteristic curves demonstrate suppressed I off 's associated with Drain
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2654cea0a5bf68f519be1cb4810101b4
https://doi.org/10.1109/icasi.2017.7988552
https://doi.org/10.1109/icasi.2017.7988552
Autor:
Ting-Wei Lu, 呂庭維
103
In global competition, multinational corporations (MNCs) constantly compete with their competitors in multiple markets. Most of prior researches for multipoint competition have proposed the concept called mutual forbearance, which indicates
In global competition, multinational corporations (MNCs) constantly compete with their competitors in multiple markets. Most of prior researches for multipoint competition have proposed the concept called mutual forbearance, which indicates
Externí odkaz:
http://ndltd.ncl.edu.tw/handle/04130590856306792192
Publikováno v:
The FASEB Journal. 24
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fdfc8917be854a271129e7fe8b4e41ff
https://doi.org/10.1096/fasebj.24.1_supplement.566.10
https://doi.org/10.1096/fasebj.24.1_supplement.566.10
Autor:
Raed Al-Rajabi, Norma S. Ketchum, Joel E. Michalek, Devalingam Mahalingam, Ting-Wei Lu, Sukeshi R. Patel
Publikováno v:
Journal of Clinical Oncology. 33:e15150-e15150
e15150 Background: HCC pts often present with Child Pugh (CP) B liver dysfunction but are poorly represented in trials. GIDEON showed median dose (duration) was 742 mg (17.6 weeks) in CP A vs 677 m...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9a3812e539e74fc1b7ceeff7437f366a
https://doi.org/10.1200/jco.2015.33.15_suppl.e15150
https://doi.org/10.1200/jco.2015.33.15_suppl.e15150
Autor:
Raed Al-Rajabi, Brad H. Pollock, Ting-Wei Lu, Sukeshi R. Patel, Devalingam Mahalingam, Joel E. Michalek, Norma S. Ketchum
Publikováno v:
Journal of Clinical Oncology. 33:369-369
369 Background: Sorafenib (SOR) is the only FDA-approved systemic therapy for advanced hepatocellular carcinoma (HCC). In clinical practice, there are limited efficacy data related to dose modifications, which are often required. Given the high preva
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1295712f79d097305a130f8d90fd61af
https://doi.org/10.1200/jco.2015.33.3_suppl.369
https://doi.org/10.1200/jco.2015.33.3_suppl.369